BonGeo Pharmaceuticals Inc.
BonGeo Pharmaceuticals Inc., headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in innovative therapies for chronic diseases. Founded in 2010, the company has made significant strides in research and development, focusing on areas such as oncology and autoimmune disorders. With a commitment to advancing healthcare, BonGeo Pharmaceuticals offers a unique portfolio of biologics and small molecule drugs that stand out for their efficacy and safety profiles. The company has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. Recognised for its dedication to quality and innovation, BonGeo Pharmaceuticals continues to expand its operational reach, aiming to improve patient outcomes globally while maintaining a strong presence in the US and other key markets.
DitchCarbon Score
How does BonGeo Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BonGeo Pharmaceuticals Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BonGeo Pharmaceuticals Inc.'s reported carbon emissions
BonGeo Pharmaceuticals Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the pharmaceutical industry increasingly focuses on sustainability, BonGeo Pharmaceuticals may need to establish clear climate commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BonGeo Pharmaceuticals Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
